IV NAD+ in the UK: where it is offered and what to ask

IV NAD+ is the most visible and most expensive way to encounter NAD+ in the UK. This post covers what a session actually involves and what to ask before booking. It is editorial commentary, not medical advice, and we do not recommend a clinic or a course for any individual.

What IV NAD+ is

An IV NAD+ session delivers NAD+ directly into the bloodstream through a cannula, usually over several hours, and is commonly sold as a course of several sessions rather than a single visit. It is offered at private wellness and longevity clinics, sometimes alongside other intravenous “wellness drips”. The appeal clinics market is that going intravenous bypasses the gut, where, as covered in NAD+ supplements in the UK, most oral NAD+ is broken down before it can be absorbed.

What remains genuinely debated, and clinics rarely foreground this, is how much of the infused NAD+ reaches and persists in target tissues, and whether that produces meaningful clinical effects. Bypassing absorption is not the same as proving benefit.

What a session involves

The defining feature of IV NAD+ is that it is slow. Sessions run for several hours because delivering NAD+ quickly is associated with infusion-related sensations such as flushing, chest tightness or nausea, which ease when the rate is slowed. That is why a session is an afternoon commitment rather than a quick appointment. We cover the tolerability picture in NAD+ side-effects.

If the multi-hour format does not suit you, some clinics offer a quicker injection instead, compared in NAD+ injection vs IV.

The regulatory position

This is the most important thing to understand before booking. IV NAD+ is not a UK licensed medicine. It is not marketed under a Marketing Authorisation, so it sits outside medicines regulation and is offered as a private clinical service. That places the responsibility on the clinic’s own standards rather than on a medicines licence.

A clinic offering IV NAD+ should hold CQC registration in England, or the equivalent in the devolved nations. The prescribing or administering practitioner should be GMC or GPhC registered. Any pharmacy compounding the NAD+ should be GPhC registered. These are the markers of a clinic operating properly within the private-service frame.

What the evidence supports

The human evidence base for IV NAD+ specifically is thin. Much of the wider NAD+ literature rests on animal studies and on oral precursor trials, not on intravenous administration in people. Studies suggest NAD+ biology shifts with administration; studies do not establish that IV NAD+ delivers the anti-ageing or recovery outcomes it is marketed on. There are no large long-term randomised trials behind the headline claims. A clinic presenting IV NAD+ as a proven anti-ageing treatment is overstating the evidence.

What to ask before booking

Reasonable, non-clinical questions include the clinic’s CQC registration status, the registration of the person administering the drip, how the NAD+ is sourced and compounded, what the full course costs rather than a single session (see NAD+ cost in the UK), and what screening they do before agreeing to treat you. A suitably qualified healthcare professional should be assessing your suitability, not simply taking a booking.

Read next

The NAD+ sub-hub maps every route, and our UK IV therapy page covers the broader drip market. For named providers, see London IV NAD+ clinics. If you are weighing clinics more broadly, UK longevity clinics sets out the wider landscape.